Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Human Genome Sciences, Inc. (HGSI) -- Ignore unavailable to you. Want to Upgrade?

To: kenhott who wrote (1106)	8/27/2009 10:28:35 PM
From: Steven Rachbach	Read Replies (1) \| Respond to of 1127

From the GSK PR: <<The study will be stopped when approximately 1500 reports of first occurrence of MACE have occurred - estimated to be approximately three years - with interim independent analyses planned. >> Are you saying that the interim "independent analyses" will not be known to the public or GSK other than to tell them to keep going or stop because you are killing people? Thanks for your insight and knowledge. -- Steve